NCT00394745View on ClinicalTrials.gov

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
HypertensionMetabolic Syndrome
Interventions
DRUG

Valsartan

Trial Locations (2)

Unknown

Investigative Centers

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00394745 - Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter